Wednesday, July 09, 2025 3:00:46 PM
Here we go again...
Your numbers... 3200 in UK, not 3200 will get the treatment. There will be criteria, filters. Check with your favorite chatgpt grok if you want.
There is no budget for 3200...
What is the most $ the MHRA has allocated to a drug in the last 20 fiscal years... And what is the rough estimate # patients it goes towards...
The max that will ever be allocated to an expensive treatment like DCVAX yearly would be 200 million, if we are lucky. 500-800 estimate patient at $200k = $100-$160 million.
As for # of people that will fly to the UK and pay from their own pocket (or self fundraise) .... You might want to do some research on the amount of people that actually do this yearly (a 100k-200k treatment) .... The result wont be 10% of the US... And your "the rest of Europe numbers"
As for "other form of cancers" .... well in what, 20 years from now? 30 years from now... Other treatment will apear...
Your numbers... 3200 in UK, not 3200 will get the treatment. There will be criteria, filters. Check with your favorite chatgpt grok if you want.
There is no budget for 3200...
What is the most $ the MHRA has allocated to a drug in the last 20 fiscal years... And what is the rough estimate # patients it goes towards...
The max that will ever be allocated to an expensive treatment like DCVAX yearly would be 200 million, if we are lucky. 500-800 estimate patient at $200k = $100-$160 million.
As for # of people that will fly to the UK and pay from their own pocket (or self fundraise) .... You might want to do some research on the amount of people that actually do this yearly (a 100k-200k treatment) .... The result wont be 10% of the US... And your "the rest of Europe numbers"
As for "other form of cancers" .... well in what, 20 years from now? 30 years from now... Other treatment will apear...
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
